PEDeus AG was founded in the summer of 2018 as a subsidiary of the University Children's Hospital Zurich. The name PEDeus stands for "Pediatric decision support" - our core competence. In the beginning of 2019, we launched the innovative, web-based tool "PEDeDose", whose software was certified as a Class IIa medical device in December 2020. PEDeDose supports healthcare professionals in making decisions about drug dosages for children and thus ensures the safe use of pharmaceuticals.
As a provider of a medical device, it is our concern to meet the highest quality standards. We are therefore pleased that PEDeus has received from the notified body TÜV SÜD both the ISO 13485:2016 Certificate for "Design and Development, Production and Distribution of Pediatric Clinical Decision Support Software for Healthcare Professionals" and the Quality Management System Certificate according to the EU Regulation on Medical Devices (MDR). Our quality management system thus meets the strict requirements that apply to the medical device industry in Switzerland and the EU.
The proximity to the University Children's Hospital Zurich is important to us. However, the independent structure as a stock corporation allows us to implement more flexible regulatory conditions, obtain important certifications and be more agile in the eHealth market. Our Board of Directors is composed as follows:
- Daniel Staffelbach, Chairman of the Board of Directors
Attorney at Law and Partner at Walder Wyss AG
- Oliver Sack, Deputy Chairman of the Board of Directors
Managing Director of the Children's Hospital Zurich Eleonor Foundation
- Prof. Dr. med. Michael Grotzer, Member of the Board of Directors
Medical Director of the University Children's Hospital Zurich
- Sara Iten, MSc ETH Pharm. Wiss., Member of the Board of Directors
Managing Director of the Swiss Association of National Health Service and Hospital Pharmacists
- Dr. iur. Heinz Waser, Member of the Board of Directors
Executive Member of the Zurich Children's Hospital Eleonor Foundation